BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32525752)

  • 1. Treatment Complications and Survival Among Children and Young Adults With Acute Lymphoblastic Leukemia.
    Alvarez EM; Malogolowkin M; Hoch JS; Li Q; Brunson A; Pollock BH; Muffly L; Wun T; Keegan THM
    JCO Oncol Pract; 2020 Oct; 16(10):e1120-e1133. PubMed ID: 32525752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased Early Mortality in Young Adult Patients With Acute Lymphoblastic Leukemia Treated at Specialized Cancer Centers in California.
    Alvarez EM; Malogolowkin M; Li Q; Brunson A; Pollock BH; Muffly L; Wun T; Keegan THM
    J Oncol Pract; 2019 Apr; 15(4):e316-e327. PubMed ID: 30849003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of location of inpatient cancer care on patients with Ewing sarcoma and osteosarcoma-A population-based study.
    Alvarez E; Malogolowkin M; Pollock BH; Li Q; Johnston E; Marina N; Wun T; Thorpe S; Keegan T
    Pediatr Blood Cancer; 2021 Jul; 68(7):e28998. PubMed ID: 33720485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment at Specialized Cancer Centers Is Associated with Improved Survival in Adolescent and Young Adults with Soft Tissue Sarcoma.
    Alvarez E; Spunt SL; Malogolowkin M; Li Q; Wun T; Brunson A; Thorpe S; Kreimer S; Keegan T
    J Adolesc Young Adult Oncol; 2022 Aug; 11(4):370-378. PubMed ID: 34910881
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment-related toxicities associated with hospitalization in children, adolescents, and young adults with acute lymphoblastic leukemia: population level analysis.
    Namjoshi NS; Keegan THM; Li QC; Chung JH; Rosenthal JL; Winestone LE; Muffly L; Malogolowkin MH; Alvarez EM
    Leuk Lymphoma; 2022 Dec; 63(13):3191-3199. PubMed ID: 35999808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Specialized Treatment Setting on Survival in Adolescent and Young Adult ALL.
    Muffly LS; Parsons HM; Miller K; Li Q; Brunson A; Keegan TH
    JCO Oncol Pract; 2023 Dec; 19(12):1190-1198. PubMed ID: 37890123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adolescents and Young Adults with Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia: Impact of Care at Specialized Cancer Centers on Survival Outcome.
    Wolfson J; Sun CL; Wyatt L; Stock W; Bhatia S
    Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):312-320. PubMed ID: 28209594
    [No Abstract]   [Full Text] [Related]  

  • 8. Trends in survival of leukemia among children, adolescents, and young adults: A population-based study in Osaka, Japan.
    Nakata K; Okawa S; Fuji S; Sato A; Morishima T; Tada Y; Inoue M; Hara J; Kawa K; Miyashiro I;
    Cancer Sci; 2021 Mar; 112(3):1150-1160. PubMed ID: 33428808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of hospitalization among survivors of childhood and adolescent acute lymphoblastic leukemia compared to siblings and a general population sample.
    Ou JY; Smits-Seemann RR; Kaul S; Fluchel MN; Sweeney C; Kirchhoff AC
    Cancer Epidemiol; 2017 Aug; 49():216-224. PubMed ID: 28734233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival Outcome of Filipino Children With Acute Lymphoblastic Leukemia Treated With Modified Berlin-Frankfurt-Muenster/Hong Kong Acute Lymphoblastic Leukemia (BFM95/HKALL97) Protocol in a Tertiary General Hospital From January 2005 to December 2009: A Retrospective Cohort Study.
    Dujua AC; Hernandez FG
    J Pediatr Hematol Oncol; 2017 Apr; 39(3):e116-e123. PubMed ID: 28085747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adolescent and young adult oncology patients: Disparities in access to specialized cancer centers.
    Alvarez E; Keegan T; Johnston EE; Haile R; Sanders L; Saynina O; Chamberlain LJ
    Cancer; 2017 Jul; 123(13):2516-2523. PubMed ID: 28241089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical Therapy Utilization Among Hospitalized Patients With Pediatric Acute Lymphoblastic Leukemia.
    Rodwin RL; Ma X; Ness KK; Kadan-Lottick NS; Wang R
    JCO Oncol Pract; 2022 Jul; 18(7):e1060-e1068. PubMed ID: 35427182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ICU Admission in Children With Acute Lymphoblastic Leukemia in Sweden: Prevalence, Outcome, and Risk Factors.
    Ranta S; Broman LM; Abrahamsson J; Berner J; Fläring U; Hed Myrberg I; Kalzén H; Karlsson L; Mellgren K; Nilsson A; Norén-Nyström U; Palle J; von Schewelov K; Svahn JE; Törnudd L; Heyman M; Harila-Saari A
    Pediatr Crit Care Med; 2021 Dec; 22(12):1050-1060. PubMed ID: 34074998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of anti-asparaginase antibodies during therapy with E.coli asparaginase in children with newly diagnosed acute lymphoblastic leukemia and lymphoma.
    Ebeid EN; Kamel MM; Ali BA
    J Egypt Natl Canc Inst; 2008 Jun; 20(2):127-33. PubMed ID: 20029468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volume-Outcome Relationships in Pediatric Acute Lymphoblastic Leukemia: Association Between Hospital Pediatric and Pediatric Oncology Volume With Mortality and Intensive Care Resources During Initial Therapy.
    Wilkes JJ; Hennessy S; Xiao R; Rheingold S; Seif AE; Huang YS; Vendetti N; Li Y; Bagatell R; Aplenc R; Fisher BT
    Clin Lymphoma Myeloma Leuk; 2016 Jul; 16(7):404-410.e1. PubMed ID: 27246140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial.
    Vora A; Goulden N; Wade R; Mitchell C; Hancock J; Hough R; Rowntree C; Richards S
    Lancet Oncol; 2013 Mar; 14(3):199-209. PubMed ID: 23395119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Socioeconomic status and event free survival in pediatric acute lymphoblastic leukemia: a population-based cohort study.
    Gupta S; Sutradhar R; Guttmann A; Sung L; Pole JD
    Leuk Res; 2014 Dec; 38(12):1407-12. PubMed ID: 25224660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study.
    Biondi A; Schrappe M; De Lorenzo P; Castor A; Lucchini G; Gandemer V; Pieters R; Stary J; Escherich G; Campbell M; Li CK; Vora A; Aricò M; Röttgers S; Saha V; Valsecchi MG
    Lancet Oncol; 2012 Sep; 13(9):936-45. PubMed ID: 22898679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia.
    Pui CH; Cheng C; Leung W; Rai SN; Rivera GK; Sandlund JT; Ribeiro RC; Relling MV; Kun LE; Evans WE; Hudson MM
    N Engl J Med; 2003 Aug; 349(7):640-9. PubMed ID: 12917300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Birthweight and all-cause mortality after childhood and adolescent leukemia: a cohort of children with leukemia from Denmark, Norway, Sweden, and Washington State.
    Ording AG; Christensen LB; Bjørge T; Doody DR; Ekbom A; Glimelius I; Grotmol T; Larfors G; Mueller BA; Smedby KE; Tretli S; Troisi R; Sørensen HT
    Acta Oncol; 2020 Aug; 59(8):949-958. PubMed ID: 32174251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.